Adipose tissue and the insulin resistance syndrome | Proceedings of the Nutrition Society | Cambridge Core (original) (raw)

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Obesity is associated with insulin resistance. Insulin resistance underlies a constellation of adverse metabolic and physiological changes (the insulin resistance syndrome) which is a strong risk factor for development of type 2 diabetes and CHD. The present article discusses how accumulation of triacylglycerol in adipocytes can lead to deterioration of the responsiveness of glucose metabolism in other tissues. Lipodystrophy, lack of adipose tissue, is also associated with insulin resistance. Any plausible explanation for the link between excess adipose tissue and insulin resistance needs to be able to account for this observation. Adipose tissue in obesity becomes refractory to suppression of fat mobilization by insulin, and also to the normal acute stimulatory effect of insulin on activation of lipoprotein lipase (involved in fat storage). The net effect is as though adipocytes are ‘full up’ and resisting further fat storage. Thus, in the postprandial period especially, there is an excess flux of circulating lipid metabolites that would normally have been ‘absorbed’ by adipose tissue. This situation leads to fat deposition in other tissues. Accumulation of triacylglycerol in skeletal muscles and in liver is associated with insulin resistance. In lipodystrophy there is insufficient adipose tissue to absorb the postprandial influx of fatty acids, so these fatty acids will again be directed to other tissues. This view of the link between adipose tissue and insulin resistance emphasises the important role of adipose tissue in ‘buffering’ the daily influx of dietary fat entering the circulation and preventing excessive exposure of other tissues to this influx.

References

Banerji, MA, Buckley, MC, Chaiken, RL, Gordon, D, Lebovitz, HE & Kral, JG (1995) Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. International Journal of Obesity 19, 846–850.Google ScholarPubMed

Björntorp, P (1994) Fatty acids, hyperinsulinemia, and insulin resistance: which comes first? Current Opinion in Lipidology 5, 166–174.CrossRefGoogle ScholarPubMed

Björntorp, P (1995) Liver triglycerides and metabolism. International Journal of Obesity 19, 839–840.Google ScholarPubMed

Blaak, EE, Van Baak, MA, Kemerink, GJ, Pakbiers, MT, Heidendal, GA & Saris, WH (1994) β-adrenergicstimulation of energy expenditure and forearm skeletal muscle metabolism in lean and obese men. American Journal of Physiology 267, E306–E315.Google ScholarPubMed

Boden, G, Chen, X, Ruiz, J, White, JV & Rossetti, L (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. Journal of Clinical Investigation 93, 2438–2446.CrossRefGoogle ScholarPubMed

Bogardus, C, Lillioja, S, Mott, DM, Hollenbeck, C & Reaven, G (1985) Relationship between degree of obesity and in vivo insulin action in man. American Journal of Physiology 248, E286–E291.Google ScholarPubMed

Brunzell, JD & Hokanson, JE (1999) Dyslipidemia of central obesity and insulin resistance. Diabetes Care 22, Suppl. 3, C10–C13.Google ScholarPubMed

Campbell, PJ, Carlson, MG & Nurjhan, N (1994) Fat metabolism in human obesity. American Journal of Physiology 266, E600–E605.Google ScholarPubMed

Cao, H & Hegele, RA (2000) Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Human and Molecular Genetics 9, 109–112.CrossRefGoogle ScholarPubMed

Carpentier, A, Mittelman, SD, Lamarche, B, Bergman, RN, Giacca, A & Lewis, GF (1999) Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. American Journal of Physiology 276, E1055–E1066.Google ScholarPubMed

Clausen, JO, Borch-Johnsen, K, Ibsen, H, Bergman, RN, Hougaard, P, Winther, K & Pedersen, O (1996) Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. Journal of Clinical Investigation 98, 1195–1209.CrossRefGoogle Scholar

Colberg, SR, Simoneau, J-A, Thaete, FL & Kelley, DE (1995) Skeletal muscle utilization of free fatty acids in women with visceral obesity. Journal of Clinical Investigation 95, 1846–1853.CrossRefGoogle ScholarPubMed

Considine, RV, Sinha, MK, Heiman, ML, Kriauciunas, A, Stephens, TW, Nyce, MR, Ohannesian, JP, Marco, CC, McKee, LJ, Bauer, TL & Caro, JF (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New England Journal of Medicine 334, 292–295.CrossRefGoogle ScholarPubMed

Coppack, SW, Evans, RD, Fisher, RM, Frayn, KN, Gibbons, GF, Humphreys, SM, Kirk, MJ, Potts, JL & Hockaday, TDR (1992) Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism 41, 264–272.CrossRefGoogle ScholarPubMed

Coppack, SW, Fisher, RM, Gibbons, GF, Humphreys, SM, McDonough, MJ, Potts, JL & Frayn, KN (1990) Postprandial substrate deposition in human forearm and adipose tissues in vivo. Clinical Science 79, 339–348.CrossRefGoogle ScholarPubMed

Eckel, RH (1987) Adipose tissue lipoprotein lipase. In Lipoprotein Lipase, pp. 79–132 [Borensztajn, J, editor]. Chicago, IL: Evener.Google ScholarPubMed

Ellis, BA, Poynten, A, Lowy, AJ, Furler, SM, Chisholm, DJ, Kraegen, EW & Cooney, GJ (2000) Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. American Journal of Physiology 279, E554–E560.Google ScholarPubMed

Farese, RV, Yost, TJ & Eckel, RH (1991) Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans. Metabolism 40, 214–216.CrossRefGoogle ScholarPubMed

Ferrannini, E, Barrett, EJ, Bevilacqua, S & DeFronzo, RA (1983) Effect of fatty acids on glucose production and utilization in man. Journal of Clinical Investigation 72, 1737–1747.CrossRefGoogle ScholarPubMed

Flatt, J-P (1972) Role of the increased adipose tissue mass in the apparent insulin insensitivity of obesity. American Journal of Clinical Nutrition 25, 1189–1192.CrossRefGoogle ScholarPubMed

Flatt, JP (1988) Importance of nutrient balance in body weight regulation. Diabetes/Metabolism Reviews 4, 571–581.CrossRefGoogle ScholarPubMed

Forouhi, NG, Jenkinson, G, Thomas, EL, Mullick, S, Mierisova, S, Bhonsle, U, McKeigue, PM & Bell, JD (1999) Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men. Diabetologia 42, 932–935.CrossRefGoogle ScholarPubMed

Frayn, KN (1993) Insulin resistance and lipid metabolism. Current Opinion in Lipidology 4, 197–204.CrossRefGoogle Scholar

Frayn, KN, Coppack, SW, Humphreys, SM, Fisher, RM & Allman, RFC (1991) Adipose tissue insulin resistance in obesity: protective mechanism or risk factor for heart disease? International Journal of Obesity 15, Suppl. 1, 55 Abstr.Google Scholar

Gavrilova, O, Marcus Samuels, B, Graham, D, Kim, JK, Shulman, GI, Castle, AL, Vinson, C, Eckhaus, M & Reitman, ML (2000) Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. Journal of Clinical Investigation 105, 271–278.CrossRefGoogle ScholarPubMed

Goto, T, Onuma, T, Takebe, K & Kral, JG (1995) The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. International Journal of Obesity 19, 841–845.Google ScholarPubMed

Grill, V & Qvigstad, E (2000) Fatty acids and insulin secretion. British Journal of Nutrition 83, Suppl. 1, S79–S84.CrossRefGoogle ScholarPubMed

Hauner, H, Bender, M, Haastert, B & Hube, F (1998) Plasma concentrations of soluble TNF-alpha receptors in obese subjects. International Journal of Obesity 22, 1239–1243.CrossRefGoogle ScholarPubMed

Himsworth, HP (1936) Diabetes mellitus. Its differentiation into insulin-sensitive and insulin-insensitive types. Lancet i, 127–130.CrossRefGoogle Scholar

Hofmann, C, Lorenz, K, Braithwaite, SS, Colca, JR, Palazuk, BJ, Hotamisligil, GS & Spiegelman, BM (1994) Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134, 264–270.CrossRefGoogle ScholarPubMed

Hotamisligil, GS & Spiegelman, BM (1994) Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43, 1271–1278.CrossRefGoogle ScholarPubMed

Insel, PA, Liljenquist, JE, Tobin, JD, Sherwin, RS, Watkins, P, Andres, R & Berman, M (1975) Insulin control of glucose metabolism in man. A new kinetic analysis. Journal of Clinical Investigation 55, 1057–1066.CrossRefGoogle Scholar

Jeppesen, J, Hollenbeck, CB, Zhou, M-Y, Coulston, AM, Jones, C, Chen, Y-DI, & Reaven, GM (1995) Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia. Arteriosclerosis, Thrombosis and Vascular Biology 15, 320–324.CrossRefGoogle ScholarPubMed

Kalant, D, Phélis, S, Fielding, BA, Frayn, KN, Cianflone, K & Sniderman, AD (2001) Increased postprandial fatty acid trapping in subcutaneous adipose tissue in obese women. Journal of Lipid Research 41, 1963–1968.CrossRefGoogle Scholar

Kaplan, NM (1989) The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Archives of Internal Medicine 149, 1514–1520.CrossRefGoogle ScholarPubMed

Karam, JH, Grodsky, GM & Forsham, PH (1963) Excessive insulin response to glucose in obese subjects as measured by immunochemical assay. Diabetes 12, 197–204.CrossRefGoogle ScholarPubMed

Kim, JK, Gavrilova, O, Chen, Y, Reitman, ML & Shulman, GI (2000) Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. Journal of Biological Chemistry 275, 8456–8460.CrossRefGoogle ScholarPubMed

Koistinen, HA, Bastard, JP, Dusserre, E, Ebeling, P, Zegari, N, Andreelli, F, Jardel, C, Donner, M, Meyer, L, Moulin, P, Hainque, B, Riou, JP, Laville, M, Koivisto, VA & Vidal, H (2000) Subcutaneous adipose tissue expression of tumour necrosis factor-a is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects. European Journal of Clinical Investigation 30, 302–310.CrossRefGoogle Scholar

Koyama, K, Chen, G, Lee, Y & Unger, RH (1997) Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. American Journal of Physiology 273, E708–E713.Google ScholarPubMed

Landin, K, Stigendal, L, Eriksson, E, Krotkiewski, M, Risberg, B, Tengborn, L & Smith, U (1990) Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 39, 1044–1048.CrossRefGoogle ScholarPubMed

Lewis, GFO, Meara, NM, Soltys, PA, Blackman, JD, Iverius, PH, Druetzler, AF, Getz, GS & Polonsky, KS (1990) Postprandial lipoprotein metabolism in normal and obese subjects: comparison after the vitamin A fat-loading test. Journal of Clinical Endocrinology and Metabolism 71, 1041–1050.CrossRefGoogle ScholarPubMed

Lind, L, Fugmann, A, Branth, S, Vessby, B, Millgård, J, Berne, C & Lithell, H (2000) The impairment in endothelial function induced by non-esterified fatty acids can be reversed by insulin. Clinical Science 99, 169–174.CrossRefGoogle ScholarPubMed

Miesenböck, G & Patsch, JR (1992) Postprandial hyperlipidemia: the search for the atherogenic lipoprotein. Current Opinion in Lipidology 3, 196–201.CrossRefGoogle Scholar

Mohamed-Ali, V, Goodrick, S, Rawesh, A, Katz, DR, Miles, JM, Yudkin, JS, Klein, S & Coppack, SW (1997) Subcutaneous adipose tissue secretes interleukin-6 but not tumor necrosis factor-a in vivo. Journal of Clinical Endocrinology and Metabolism 82, 4196–4200.Google ScholarPubMed

Mohamed-Ali, V, Pinkney, JH & Coppack, SW (1998) Adipose tissue as an endocrine and paracrine organ. International Journal of Obesity 22, 1145–1158.CrossRefGoogle ScholarPubMed

Ong, JM & Kern, PA (1989) Effect of feeding and obesity on lipoprotein lipase activity, immunoreactive protein, and messenger RNA levels in human adipose tissue. Journal of Clinical Investigation 84, 305–311.CrossRefGoogle ScholarPubMed

Opie, LH & Walfish, PG (1963) Plasma free fatty acid concentrations in obesity. New England Journal of Medicine 268, 757–760.CrossRefGoogle ScholarPubMed

Patsch, JR, Prasad, S, Gotto, AMJ & Bengtsson-Olivecrona, G (1984) Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase. Journal of Clinical Investigation 74, 2017–2023.CrossRefGoogle ScholarPubMed

Phillips, DIW, Caddy, S, Ilic, V, Fielding, BA, Frayn, KN, Borthwick, AC & Taylor, R (1996) Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in non-diabetic subjects. Metabolism 45, 947–950.CrossRefGoogle Scholar

Rabinowitz, D & Zierler, KL (1961) Forearm metabolism in obesity and its response to intra-arterial insulin. Evidence for adaptive hyperinsulinism. Lancet i, 690–692.CrossRefGoogle Scholar

Randle, PJ, Garland, PB, Hales, CN & Newsholme, EA (1963) The glucose-fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet i, 785–789.CrossRefGoogle Scholar

Sadur, CN & Eckel, RH (1982) Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycemic clamp technique. Journal of Clinical Investigation 69, 1119–1125.CrossRefGoogle ScholarPubMed

Saghizadeh, M, Ong, JM, Garvey, WT, Henry, RR & Kern, PA (1996) The expression of TNFa by human muscle. Relationship to insulin resistance. Journal of Clinical Investigation 97, 1111–1116.CrossRefGoogle ScholarPubMed

Shackleton, S, Lloyd, DJ, Jackson, SN, Evans, R, Niermeijer, MF, Singh, BM, Schmidt, H, Brabant, G, Kumar, S, Durrington, PN, Gregory, S, O'Rahilly, S & Trembath, RC (2000) LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nature Genetics 24, 153–156.CrossRefGoogle ScholarPubMed

Shimabukuro, M, Koyama, K, Chen, G, Wang, M-Y, Trieu, F, Lee, Y, Newgard, CB & Unger, RH (1997) Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proceedings of the National Academy of Sciences, USA 94, 4637–4641.CrossRefGoogle ScholarPubMed

Sniderman, AD, Cianflone, K, Summers, LKM, Fielding, BA & Frayn, KN (1997) The acylation-stimulating protein pathway and regulation of postprandial metabolism. Proceedings of the Nutrition Society 56, 703–712.CrossRefGoogle ScholarPubMed

Steinberg, HO, Paradisi, G, Hook, G, Crowder, K, Cronin, J & Baron, AD (2000) Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 49, 1231–1238.CrossRefGoogle ScholarPubMed

Steinberg, HO, Tarshoby, M, Monestel, R, Hook, G, Cronin, J, Johnson, A, Bayazeed, B & Baron, AD (1997) Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. Journal of Clinical Investigation 100, 1230–1239.CrossRefGoogle ScholarPubMed

Tooke, JE & Hannemann, MM (2000) Adverse endothelial function and the insulin resistance syndrome. Journal of Internal Medicine 247, 425–431.CrossRefGoogle ScholarPubMed

Unger, RH (1995) Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44, 863–870.CrossRefGoogle ScholarPubMed